Cd161-clec2d
Nk cell lectin receptor ligand human killer type function natural frontiersin immunology frontiers figure fimmu gene (pdf) overexpression of llt1 (ocil, clec2d) on prostate cancer cells Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer
Frontiers | Modulation of NK Cell Function by Genetically Coupled C
Prostate cancer nk interaction Prostate nk cell inhibits killing cells mediated overexpression interaction cancer through Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer
(pdf) blocking llt1 (clec2d, ocil)-nkrp1a (cd161) interaction enhances
Triple enhances lysis blocking negative mediated interaction killer cells breast cancer cell naturalProstate overexpression inhibits interaction cd161 mediated nk cells Overexpression prostate interaction cd161 mediated nk inhibitsCells cd8 memory cytotoxic mait frontiersin therapeutic potential high figure fimmu.
Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer .
(PDF) Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
(PDF) Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
Frontiers | Modulation of NK Cell Function by Genetically Coupled C
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer